Table 1.
Monoclonal antibody |
|||||
---|---|---|---|---|---|
Samples | F105 | 1b12 | 2F5 | 48d | 17b |
R2 | |||||
wt gp120 | 25,000a | 25,000 | <10 | 50,000 | 25,000 |
wt gp120–mC3d3 | 25,000 | 25,000 | <10 | 12,500 | 12,500 |
wt gp120 + sCD4 | 50,000 | 12,500 | <10 | 50,000 | 25,000 |
wt gp120–mC3d3 + sCD4 | 25,000 | 50,000 | <10 | 25,000 | 50,000 |
ADA | |||||
wt gp120 | 25,000 | 25,000 | <10 | 1,600 | 800 |
wt gp120–mC3d3 | 25,000 | 25,000 | <10 | 400 | 400 |
wt gp120 + sCD4 | 50,000 | 25,000 | <10 | 25,000 | 25,000 |
wt gp120–mC3d3 + sCD4 | 50,000 | 50,000 | <10 | 25,000 | 25,000 |
ADA (PM) | |||||
wt gp120 | 50,000 | 25,000 | <10 | 25,000 | 25,000 |
wt gp120–mC3d3 | 25,000 | 25,000 | <10 | 12,500 | 25,000 |
wt gp120 + sCD4 | 25,000 | 25,000 | <10 | 25,000 | 25,000 |
wt gp120–mC3d3 + sCD4 | 50,000 | 25,000 | <10 | 25,000 | 25,000 |
89.6 | |||||
wt gp120 | 25,000 | 25,000 | <10 | 3,200 | 400 |
wt gp120–mC3d3 | 25,000 | 25,000 | <10 | 400 | 400 |
wt gp120 + sCD4 | 50,000 | 25,000 | <10 | 25,000 | 50,000 |
wt gp120–mC3d3 + sCD4 | 50,000 | 25,000 | <10 | 50,000 | 50,000 |
89.6 (PM) | |||||
wt gp120 | 25,000 | 25,000 | <10 | 25,000 | 25,000 |
wt gp120–mC3d3 | 25,000 | 25,000 | <10 | 25,000 | 25,000 |
wt gp120 + sCD4 | 25,000 | 25,000 | <10 | 25,000 | 25,000 |
wt gp120–mC3d3 + sCD4 | 25,000 | 25,000 | <10 | 50,000 | 50,000 |
Value represents the inverse of the endpoint dilution titer